252 related articles for article (PubMed ID: 23916385)
1. Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management.
Salwa SP; Bourke MG; Forde PF; O'Shaughnessy M; O'Sullivan ST; Kelly EJ; Soden DM; Clover AJ
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):403-6. PubMed ID: 23916385
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of electrochemotherapy in ulcerated basal cell carcinoma.
Richetta AG; Curatolo P; D'Epiro S; Mancini M; Mattozzi C; Giancristoforo S; Rotunno R; Calvieri S
Clin Ter; 2011; 162(5):443-5. PubMed ID: 22041802
[TBL] [Abstract][Full Text] [Related]
3. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up.
Clover AJP; Salwa SP; Bourke MG; McKiernan J; Forde PF; O'Sullivan ST; Kelly EJ; Soden DM
Eur J Surg Oncol; 2020 May; 46(5):847-854. PubMed ID: 31862134
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma: 10-year experience with electrochemotherapy.
Campana LG; Marconato R; Valpione S; Galuppo S; Alaibac M; Rossi CR; Mocellin S
J Transl Med; 2017 May; 15(1):122. PubMed ID: 28569161
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin-mediated electrochemotherapy of basal cell carcinoma.
Glass LF; Fenske NA; Jaroszeski M; Perrott R; Harvey DT; Reintgen DS; Heller R
J Am Acad Dermatol; 1996 Jan; 34(1):82-6. PubMed ID: 8543699
[TBL] [Abstract][Full Text] [Related]
6. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin.
Rodríguez-Cuevas S; Barroso-Bravo S; Almanza-Estrada J; Cristóbal-Martínez L; González-Rodríguez E
Arch Med Res; 2001; 32(4):273-6. PubMed ID: 11440782
[TBL] [Abstract][Full Text] [Related]
7. Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry.
Rotunno R; Campana LG; Quaglino P; de Terlizzi F; Kunte C; Odili J; Gehl J; Ribero S; Liew SH; Marconato R; Brizio M; Curatolo P
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1147-1154. PubMed ID: 29178483
[TBL] [Abstract][Full Text] [Related]
8. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach.
Testori A; Tosti G; Martinoli C; Spadola G; Cataldo F; Verrecchia F; Baldini F; Mosconi M; Soteldo J; Tedeschi I; Passoni C; Pari C; Di Pietro A; Ferrucci PF
Dermatol Ther; 2010; 23(6):651-61. PubMed ID: 21054709
[TBL] [Abstract][Full Text] [Related]
9. Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas.
Kis EG; Baltás E; Ócsai H; Vass A; Németh IB; Varga E; Oláh J; Kemény L; Tóth-Molnár E
Sci Rep; 2019 Mar; 9(1):4285. PubMed ID: 30862897
[TBL] [Abstract][Full Text] [Related]
10. Metastatic basal cell carcinoma with squamous differentiation: report of a case with response of cutaneous metastases to electrochemotherapy.
Fantini F; Gualdi G; Cimitan A; Giannetti A
Arch Dermatol; 2008 Sep; 144(9):1186-8. PubMed ID: 18794464
[TBL] [Abstract][Full Text] [Related]
11. Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients.
Gargiulo M; Papa A; Capasso P; Moio M; Cubicciotti E; Parascandolo S
Ann Surg; 2012 Jun; 255(6):1158-64. PubMed ID: 22549747
[TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases.
Quaglino P; Mortera C; Osella-Abate S; Barberis M; Illengo M; Rissone M; Savoia P; Bernengo MG
Ann Surg Oncol; 2008 Aug; 15(8):2215-22. PubMed ID: 18498012
[TBL] [Abstract][Full Text] [Related]
13. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.
Möller MG; Salwa S; Soden DM; O'Sullivan GC
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1611-30. PubMed ID: 19895245
[TBL] [Abstract][Full Text] [Related]
14. Intralesional agents in the management of cutaneous malignancy: a review.
Good LM; Miller MD; High WA
J Am Acad Dermatol; 2011 Feb; 64(2):413-22. PubMed ID: 20334952
[TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent.
Solari N; Spagnolo F; Ponte E; Quaglia A; Lillini R; Battista M; Queirolo P; Cafiero F
J Surg Oncol; 2014 Mar; 109(3):270-4. PubMed ID: 24165992
[TBL] [Abstract][Full Text] [Related]
16. Electrochemotherapy with intravenous bleomycin for advanced non-melanoma skin cancers and for cutaneous and subcutaneous metastases from melanoma.
Tomassini GM; Covarelli P; Tomassini MA; Corsi A; Bianchi L; Hansel K; Stingeni L
G Ital Dermatol Venereol; 2016 Oct; 151(5):499-506. PubMed ID: 27595201
[TBL] [Abstract][Full Text] [Related]
17. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma.
Glass LF; Jaroszeski M; Gilbert R; Reintgen DS; Heller R
J Am Acad Dermatol; 1997 Oct; 37(4):596-9. PubMed ID: 9344200
[TBL] [Abstract][Full Text] [Related]
18. Intralesional Bleomycin as an Adjunct Therapeutic Modality in Eyelid and Extraocular Malignancies and Tumors.
Meyer D; Gooding C
Middle East Afr J Ophthalmol; 2015; 22(4):410-4. PubMed ID: 26692709
[TBL] [Abstract][Full Text] [Related]
19. Utility of electrochemotherapy in melanoma treatment.
Testori A; Rossi CR; Tosti G
Curr Opin Oncol; 2012 Mar; 24(2):155-61. PubMed ID: 22249204
[TBL] [Abstract][Full Text] [Related]
20. Predicting patients at risk for pain associated with electrochemotherapy.
Quaglino P; Matthiessen LW; Curatolo P; Muir T; Bertino G; Kunte C; Odili J; Rotunno R; Humphreys AC; Letulé V; Marenco F; Cuthbert C; Albret R; Benazzo M; De Terlizzi F; Gehl J
Acta Oncol; 2015 Mar; 54(3):298-306. PubMed ID: 25591818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
